SEC Form 4 · accession 0001209191-15-020401
Revance Therapeutics, Inc. · RVNC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip J. Vickers
Director
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479290
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.46 | Feb 26, 2015 | A | 18,000 | A | — | Feb 25, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The shares subject to this stock option shall vest on the one year anniversary of February 26, 2015, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date.